26 USD
0 (0%)
Last: Jan 30, 2026, 08:25 PM
We assign a fundamental rating of 5 out of 10 to XOMAP. XOMAP was compared to 525 industry peers in the Biotechnology industry. XOMAP has a medium profitability rating, but doesn't score so well on its financial health evaluation. XOMAP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- XOMAP had positive earnings in the past year.
- In the past year XOMAP had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: XOMAP reported negative net income in multiple years.
- In multiple years XOMAP reported negative operating cash flow during the last 5 years.
1.2 Ratios
- XOMAP has a Return On Assets of 3.75%. This is amongst the best in the industry. XOMAP outperforms 89.90% of its industry peers.
- With an excellent Return On Equity value of 9.14%, XOMAP belongs to the best of the industry, outperforming 92.57% of the companies in the same industry.
- XOMAP has a Return On Invested Capital of 3.31%. This is amongst the best in the industry. XOMAP outperforms 90.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 9.14% | ||
| ROIC | 3.31% |
ROA(3y)-14.85%
ROA(5y)-6.52%
ROE(3y)-31.32%
ROE(5y)-15.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- XOMAP's Profit Margin of 20.96% is amongst the best of the industry. XOMAP outperforms 93.71% of its industry peers.
- With an excellent Operating Margin value of 20.92%, XOMAP belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.92% | ||
| PM (TTM) | 20.96% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- XOMAP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, XOMAP has more shares outstanding
- XOMAP has more shares outstanding than it did 5 years ago.
- XOMAP has a worse debt/assets ratio than last year.
2.2 Solvency
- XOMAP has an Altman-Z score of -4.54. This is a bad value and indicates that XOMAP is not financially healthy and even has some risk of bankruptcy.
- XOMAP's Altman-Z score of -4.54 is in line compared to the rest of the industry. XOMAP outperforms 40.76% of its industry peers.
- A Debt/Equity ratio of 0.87 indicates that XOMAP is somewhat dependend on debt financing.
- XOMAP has a worse Debt to Equity ratio (0.87) than 73.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.54 |
ROIC/WACC0.36
WACC9.09%
2.3 Liquidity
- A Current Ratio of 3.91 indicates that XOMAP has no problem at all paying its short term obligations.
- XOMAP has a Current ratio of 3.91. This is comparable to the rest of the industry: XOMAP outperforms 46.67% of its industry peers.
- XOMAP has a Quick Ratio of 3.91. This indicates that XOMAP is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of XOMAP (3.91) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.91 | ||
| Quick Ratio | 3.91 |
3. Growth
3.1 Past
- XOMAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 135.71%, which is quite impressive.
- The Revenue has grown by 103.96% in the past year. This is a very strong growth!
- Measured over the past years, XOMAP shows a quite strong growth in Revenue. The Revenue has been growing by 9.17% on average per year.
EPS 1Y (TTM)135.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%144.03%
Revenue 1Y (TTM)103.96%
Revenue growth 3Y-9.28%
Revenue growth 5Y9.17%
Sales Q2Q%29.93%
3.2 Future
- The Earnings Per Share is expected to grow by 37.32% on average over the next years. This is a very strong growth
- Based on estimates for the next years, XOMAP will show a very strong growth in Revenue. The Revenue will grow by 41.64% on average per year.
EPS Next Y157.93%
EPS Next 2Y46.72%
EPS Next 3Y37.32%
EPS Next 5YN/A
Revenue Next Year73.62%
Revenue Next 2Y49.83%
Revenue Next 3Y34.18%
Revenue Next 5Y41.64%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- XOMAP is valuated quite expensively with a Price/Earnings ratio of 34.67.
- XOMAP's Price/Earnings ratio is rather cheap when compared to the industry. XOMAP is cheaper than 92.19% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.30. XOMAP is valued slightly more expensive when compared to this.
- Based on the Price/Forward Earnings ratio of 82.69, the valuation of XOMAP can be described as expensive.
- Based on the Price/Forward Earnings ratio, XOMAP is valued cheaply inside the industry as 88.38% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 25.57. XOMAP is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.67 | ||
| Fwd PE | 82.69 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, XOMAP is valued cheaply inside the industry as 92.38% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 31.48 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as XOMAP's earnings are expected to grow with 37.32% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y46.72%
EPS Next 3Y37.32%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 8.29%, XOMAP is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 1.08, XOMAP pays a better dividend. On top of this XOMAP pays more dividend than 99.62% of the companies listed in the same industry.
- XOMAP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.29% |
5.2 History
- XOMAP has been paying a dividend for over 5 years, so it has already some track record.
- XOMAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- 55.43% of the earnings are spent on dividend by XOMAP. This is a bit on the high side, but may be sustainable.
DP55.43%
EPS Next 2Y46.72%
EPS Next 3Y37.32%
XOMA ROYALTY CORP - XOMA 8 5/8 PERP / XOMAP FAQ
What is the ChartMill fundamental rating of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) stock?
ChartMill assigns a fundamental rating of 5 / 10 to XOMAP.
Can you provide the valuation status for XOMA ROYALTY CORP - XOMA 8 5/8 PERP?
ChartMill assigns a valuation rating of 4 / 10 to XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP). This can be considered as Fairly Valued.
What is the profitability of XOMAP stock?
XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for XOMAP stock?
The Price/Earnings (PE) ratio for XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) is 34.67 and the Price/Book (PB) ratio is 2.98.
Can you provide the financial health for XOMAP stock?
The financial health rating of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) is 3 / 10.